CPT® Code 90706

Deleted

1. Indications

The Rubella virus vaccine is indicated for the prevention of rubella, a contagious viral infection that can cause serious complications, particularly in pregnant women, including congenital rubella syndrome in the fetus. Vaccination is essential for individuals who are at risk of exposure to the virus, including children, adolescents, and adults who have not been previously vaccinated or have not had the disease. The vaccine is also recommended for women of childbearing age to ensure immunity before pregnancy.

• Prevention of Rubella The primary indication for administering the Rubella virus vaccine is to prevent rubella infection, which can lead to severe health issues, especially in pregnant women.
• Protection Against Congenital Rubella Syndrome Vaccination is crucial for women of childbearing age to protect against congenital rubella syndrome, which can result in serious birth defects.
• Immunization of At-Risk Populations The vaccine is indicated for children, adolescents, and adults who are at risk of exposure and have not been previously vaccinated or infected with rubella.

2. Procedure

The procedure for administering the Rubella virus vaccine involves several key steps to ensure proper delivery and effectiveness of the vaccine. First, the healthcare provider prepares the vaccine by checking the expiration date and ensuring that it has been stored correctly. The vaccine is typically supplied in a vial and must be reconstituted if it is in a freeze-dried form. Once prepared, the provider selects an appropriate site for subcutaneous injection, usually the outer aspect of the upper arm or the thigh for infants. The skin at the injection site is cleaned with an antiseptic wipe to minimize the risk of infection. The provider then uses a sterile syringe and needle to draw up the vaccine, ensuring that no air bubbles are present in the syringe. The needle is inserted at a 45-degree angle into the subcutaneous tissue, and the vaccine is injected slowly. After the injection, the provider may apply gentle pressure to the site with a cotton ball or gauze, and a bandage may be applied if necessary. The patient is then monitored for a brief period to observe for any immediate adverse reactions.

• Step 1: Vaccine Preparation The healthcare provider checks the expiration date and storage conditions of the vaccine, preparing it for administration.
• Step 2: Site Selection and Cleaning An appropriate site for subcutaneous injection is selected, and the area is cleaned with an antiseptic wipe.
• Step 3: Injection The vaccine is drawn into a sterile syringe, and the needle is inserted into the subcutaneous tissue at a 45-degree angle for injection.
• Step 4: Post-Injection Care After administering the vaccine, gentle pressure is applied to the injection site, and monitoring for immediate reactions is conducted.

3. Post-Procedure

After the administration of the Rubella virus vaccine, patients are typically advised to remain in the healthcare setting for a short period to monitor for any immediate adverse reactions, such as allergic responses. Common side effects may include mild soreness at the injection site, low-grade fever, or a rash, which usually resolve on their own. Patients should be informed about these potential side effects and advised to report any unusual or severe reactions. It is also important to document the vaccination in the patient's medical record, including the date of administration, the vaccine lot number, and the site of injection. Follow-up appointments may be scheduled as part of routine immunization schedules to ensure that individuals receive all necessary vaccinations, including combination vaccines that may include rubella.